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King Sau
osting by EAbstract Retinal glial tumors and pseudotumors can be classiﬁed into astrocytic hamartoma,
acquired retinal astrocytoma, massive gliosis, and focal nodular gliosis. Each has different clinical
manifestations. Astrocytic hamartoma is usually seen patients who have some manifestations of
tuberous sclerosis complex (TSC). It can occur as a noncalciﬁed or calciﬁed variety, and often a
combination of the two, and has fairly typical features with ﬂuorescein angiography, ultrasonogra-
phy, and optical coherence tomography. Although it is generally a stationary lesion, an aggressive
variant seen in very young children with TSC can lead to exudative retinopathy, retinal detachment,
and neovascular glaucoma. Acquired astrocytoma general occurs in somewhat older individuals
who do not have TSC. Like the aggressive form of astrocytic hamartoma it can lead to exudative
retinopathy and exudative retinal detachment. Pseudoneoplastic diffuse retinal gliosis can occur as
massive glial proliferation in eyes with prior trauma, Coats disease, retinal angiomatosis and other
conditions and often occurs in blind eyes. Pseudoneoplastic focal retinal gliosis is characterized by a
very superﬁcial, white, noncalciﬁed lesion in otherwise normal eye in somewhat older individuals.
Recognition of these glial lesions is important because they can resemble malignant tumors and
have different clinical courses and complications.
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Like the central nervous system, the retina contains supportive
glial cells known as astrocytes. These cells spawn several reac-
tive processes that can assume clinical importance. The most
common ones include surface wrinkling retinopathy, the gliosis
that follows retinal hemorrhage, trauma, or tumors like com-
bined retina hamartoma and retinal hemangioblastoma. In
such cases the gliosis itself does not assume tumorous propor-
tions and is not usually considered in the differential diagnosis
of glial tumors. This review describes the clinical features of se-
lected tumors and pseudotumors presumed to be of retinal glial
cell origin. These include astrocytic hamartoma, acquired reti-
nal astrocytoma, massive gliosis, and idiopathic focal pseudo-
neoplastic gliosis of the retina (Shields and Shields, 2009;
Nyboer et al., 1976; Margo et al., 1993; Mullaney et al., 1997;
Shields et al., 2004a,b, 2005, 1995, 1996; Zimmer-Galler and
Robertson, 1995; Mennel et al., 2005; Jost and Olk, 1986;
Drewe et al., 1985; Ulbright et al., 1984; Coppeto et al., 1982;
Kroll et al., 1981; Reeser et al., 1978; Eagle et al., 2000; Gunduz
et al., 1999; Cohen et al., 2008; Ramsay et al., 1979; Reeser
et al., 1978; Bornfeld et al., 1987; Yanoff et al., 1971; Nowinski
et al., 1984; Gelisken et al., 2004; Berger et al., 1979; Green,
1967; Ryan, 1954; Demirci et al., 2002; Khawly et al., 1999).
2. Retinal astrocytic hamartoma
Retinal astrocytic hamartoma is a benign tumor that is com-
posed of a proliferation of well differentiated astrocytes
(Shields and Shields, 2005, 2009; Nyboer et al., 1976; Margo
et al., 1993; Mullaney et al., 1997; Shields et al., 2004a, 1996,
2005; Zimmer-Galler and Robertson, 1995; Mennel et al.,
2005; Jost and Olk, 1986; Drewe et al., 1985; Ulbright et al.,
1984; Coppeto et al., 1982; Kroll et al., 1981; Reeser et al.,
1978; Eagle et al., 2000; Gunduz et al., 1999; Cohen et al.,
2008). It is believed to be congenital in most cases but it can be-
come clinically apparent sometime after birth. It is frequently
associated with tuberous sclerosis complex (TSC), a syndrome
that includes various combinations brain astrocytoma, cutane-
ous angioﬁbromas (‘‘adenoma sebaceum’’), cutaneous depig-mented macules (ash-leaf sign), cardiac rhabdomyoma, renal
angiomyolipoma, and other hamartomas (Shields and Shields,
2005, 2009; Nyboer et al., 1976). In those cases that are part of
TSC, various genetic alterations have been identiﬁed on chro-
mosomes 9 and 16. Some patients have only the retinal tumor
without additional ﬁndings of TSC. It is still undetermined
whether they represent a separate entity or a forme fruste, or
partial expression, of TSC. An identical fundus tumor is occa-
sionally seen in patients with neuroﬁbromatosis type 1.2.1. Clinical features
Ophthalmoscopically, retinal astrocytic hamartoma can show
considerable variation from case to case. The twomost common
variations are the noncalciﬁed tumor, the calciﬁed tumor or,
more commonly, a combination of the two. The noncalciﬁed
variant appears as a small gray-yellow, sessile of slightly elevated
lesion in the inner aspect of the sensory retina. It can occasion-
ally be transparent and fairly ﬂat, sometimes suggesting reactive
gliosis. Slightly larger lesions have a gray-yellow color and may
cause adjacent retinal traction. The calciﬁed variant may have
minimal calciﬁcation or may be totally calciﬁed. The character-
istic feature is glistening yellow spherules of calciﬁcation.
In contrast to retinoblastoma, astrocytic hamartoma show
glistening yellow calciﬁcation that differs from the more dull,
chalky calciﬁcation that characterizes retinoblastoma. It does
not usually develop prominent retinal feeding and draining
blood vessels, and often causes retinal traction, a ﬁnding not
usually seen with untreated retinoblastoma. Vitreous seeding
of the tumor and hemorrhage can sometimes occur (Kroll
et al., 1981; Cohen et al., 2008).
Although astrocytic hamartoma was historically consid-
ered to be a relatively stable lesion, there are recent reports
of progressive growth and locally malignant behavior (Shields
et al., 2005; Gunduz et al., 1999). These aggressive astrocytic
hamartomas can cause exudative retinal detachment and neo-
vascular glaucoma, ultimately requiring enucleation. Extraoc-
ular extension into the orbital and epibulbar tissues has been
recognized in these cases (Shields et al., 2005; Gunduz et al.,
1999).
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Retinal astrocytic hamartoma, particularly the calciﬁed vari-
ant, usually shows autoﬂuorescence (Mennel et al., 2005).
Fluorescein angiography of the typical lesion shows a charac-
teristic network of small blood vessels in the venous phase with
fairly intense late staining. In the case of a calciﬁed lesion,
ultrasonography shows a calciﬁed plaque as might be seen with
choroidal osteoma or calciﬁed retinoblastoma. OCT can be
used to document the retinal location and highly reﬂective fea-
tures of retinal astrocytic hamartoma. It has very typical,
although not pathognomonic, features (Shields et al., 2004a).
Cytopathologic study of ﬁne needle aspiration biopsy can be
employed to make the diagnosis in atypical cases (Shields
et al., 1996).
2.3. Pathology
Histopathologically, astrocytic hamartoma is usually com-
posed of elongated ﬁbrous astrocytes that have small uniform
nuclei and interlacing cytoplasmic processes. Areas of calciﬁca-
tion may be present, often in the form of calcospheres (Shields
and Shields, 2009). Some larger tumors may be comprised of
moderately pleomorphic gemistocytic astrocytes (Shields and
Shields, 2009; Shields et al., 2005). The less common locally
invasive variant is generally located on the optic disc and has
large, poorly-differentiated cells similar to the subependymal
astrocytomas that are seen in the brain in some patients with
TSC (Shields et al., 2005).
2.4. Management
The majority of astrocytic hamartomas are small, extrafoveal,
stationary lesions, with little or no tendency to grow or cause
complications (Zimmer-Galler and Robertson, 1995). How-
ever, they should be followed periodically because some can
show progressive growth, exudative retinal detachment, and
neovascular glaucoma (Shields et al., 2005). When a lesion is
growing and is suspected to have potential for such prolifera-
tion, then treatment is warranted. Depending of the circum-
stances, laser photocoagulation, cryotherapy, or vitrectomy
and retinal detachment surgery may be necessary. Some cases
of the giant cell variant have required enucleation because of
severe neovascular glaucoma. However, we believe that if such
a tumor is detected early, treatment with irradiation or other
methods might possibly achieve tumor control and avoid
enucleation.3. Acquired retinal astrocytoma
Retinal astrocytic hamartoma accounts for the majority of
true glial tumors of the sensory retina and in most instances
it is associated with other signs of TSC. The typical case that
is unassociated with clinically evident TSC may represent a
forme fruste of tuberous sclerosis in which only the ocular fea-
tures are manifest. Occasionally, however, the retina can
spawn an acquired astrocytoma in somewhat older individuals
who have no family history or clinical manifestations of TSC
(Shields and Shields, 2009; Ramsay et al., 1979; Reeser et al.,
1978; Bornfeld et al., 1987; Shields et al., 2004b). We chooseto call this lesion an acquired retinal astrocytoma, as opposed
to the congenital astrocytic hamartoma of TSC (Shields and
Shields, 2009). Most such tumors appear to be different from
a clinical standpoint. They may represent the retinal equivalent
of a low grade astrocytoma.
3.1. Clinical features
Acquired retinal astrocytoma appears as a solitary mass that
arises in the sensory retina. It typically is yellow and has abun-
dant intrinsic vascularity that is best visualized with ﬂuorescein
angiography. Unlike the typical congenital astrocytic hamar-
toma, it generally lacks clinically evident calciﬁcation, is more
likely to exhibit slowly progressive growth, and is not associ-
ated with TSC. Intraretinal exudation and secondary retinal
detachment usually occur as the tumor enlarges (Shields and
Shields, 2009; Ramsay et al., 1979; Reeser et al., 1978; Born-
feld et al., 1987; Shields et al., 2004b).
3.2. Diagnostic approaches
Fluorescein angiography characteristically shows small, well-
deﬁned ﬁne blood vessels in the tumor in the vascular ﬁlling
phases and diffuse late staining. Retinal feeder vessels can be
apparent, but they are not dilated and tortuous like those seen
with retinoblastoma and retinal hemangioblastoma. Ultraso-
nography usually discloses a noncalciﬁed retinal mass with
high internal reﬂectivity (Shields and Shields, 2009).
3.3. Pathology
Histopathologically, acquired retinal astrocytoma is composed
of mature glial cells, similar to the astrocytic hamartoma.
However, they do not tend to have the extensive calciﬁcation
that characterizes many astrocytic hamartomas. Some tumors
have large round cells with glassy eosinophilic cytoplasm (gem-
istocytes) similar to an equivalent tumor in the brain (Shields
and Shields, 2009).
3.4. Management
In several reported cases, the affected eye has been enucleated
because of growth and secondary glaucoma and/or because of
suspicion that the lesion is a choroidal melanoma. Hence, no
clear cut management is established. It is quite likely that if ac-
quired retinal astrocytoma can be diagnosed earlier that laser
photocoagulation, cryotherapy, or radiotherapy could control
the tumor and prevent its complications.
4. Massive pseudoneoplastic gliosis of the retina
Massive retinal gliosis is a term used to deﬁne an extensive pro-
liferation of glial cells that attains tumorous proportions. We
prefer to not use the term massive gliosis for all such cases,
since many are visible retinal nodules that are not massive. It
occurs most often in eyes with chronic inﬂammation, prior
ocular trauma, Coats’ disease, retinal hemangioblastoma, or
congenital malformations. In some instances reactive gliosis
can occur in an area of chronic retinal detachment or on a
scleral buckle from retinal detachment surgery. Such lesions
200 J.A. Shields, C.L. Shieldsare very similar clinically to a secondary vasoproliferative tu-
mor, which is listed under the rubric of retinal vascular tumors
(Shields and Shields, 2009; Shields et al., 1995). In such in-
stances, such extensive gliosis can show visible intraretinal
and subretinal exudation. In others, it is not diagnosed clini-
cally, but is recognized histopathologically after enucleation
of a blind, uncomfortable eye (Nowinski et al., 1984).
Histopathologically, massive gliosis consists of a mass of
closely arranged, well differentiated astrocytes similar to astro-
cytic hamartoma or acquired retinal astrocytoma. It is often
markedly vascular, raising the possibility that some cases
may represent a primary vascular tumor with secondary
gliosis.Figure 1 (A) Noncalciﬁed astrocytic hamartoma. (B) Calciﬁed astroc
appearance of sectioned globe of eye shown in ﬁgure 304-1, disclosing
retinal astrocytoma fundus. (F) Focal pseudoneoplastic gliosis of the5. Focal pseudoneoplastic gliosis of the retina
We have seen a few unusual cases of focal presumed glial tu-
mors in the inner retina in eyes with clear media and no prior
ocular insults (Shields and Shields, 2009). It typically appears
ophthalmoscopically as a solitary, white-yellow, superﬁcial ret-
inal lesion with no signiﬁcant exudation or retinal traction.
(Fig. 1) One similar lesion has been observed to spontaneously
resolve and another has been observed to appear spontane-
ously and show rather rapid growth (Khawly et al., 1999).
There are no speciﬁc ﬁndings with ancillary diagnostic studies
like ﬂuorescein angiography or ultrasonography. OCT shows
an abruptly elevated retinal lesion.ytic hamartoma. (C) Aggressive astrocytic hamartoma. (D) Gross
exophytic retinal mass and total retinal detachment. (E) Acquired
retina.
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Several interesting tumors and pseudotumors can arise from
glial cells in the retina. They are generally benign and have
no tendency to metastasize, but can sometimes exhibit aggres-
sive local behavior. Glial tumors discussed herein include
retinal astrocytic hamartoma seen with TSC, acquired astrocy-
toma, massive gliosis, and focal gliosis. The eye physician
should be able to recognized such lesions and differentiate
them from other benign and malignant fundus conditions.Acknowledgements
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